BioLife Solutions Inc. (Nasdaq: BLFS) entered a ten-year agreement to supply Kite Pharma with CryoStor clinical grade freeze media for cells and tissues sending the stock price soaring 80 cents to close at $2.37.
BioLife Solutions enters 10-year agreement
July 11, 2016 at 18:41 PM EDT
